|
Sign In to gain access to subscriptions and/or personal tools.
|
Hepatoblastomas in Mice in the US National Toxicology Program (NTP) Studies
Vladimir S. Turusov
NN Blokhin Cancer Research Centre, 24 Kashirskoye Shosse, 115446 Moscow, Russian Federation
Mikinori Tor
Drug Safety Evaluation, Developmental Research Labs., Shionogi and Co., Ltd, 3-1-1 Futaba, Toyonaka, Osaka 561-0825, Japan
Robert C. Sills
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709
Gabrielle A. Willson
Experimental Pathology Laboratories, PO Box 12766, Research Triangle Park, North Carolina 27709, USA
Ronald A. Herbert
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709
James R. Hailey
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709
Joseph K. Haseman
Environmental Diseases and Medicine Program, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709
Gary A. Boorman
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709, boorman{at}niehs.nih.gov
Over the last 8 years, a 5-fold increase in the incidence of mice with spontaneous hepatoblastomas and a moderate increase in the incidence of chemically induced hepatoblastomas in B6C3F1 mice occurred in 2-year NTP studies compared to the previous 7 years. There was a positive association between an increased incidence of mice with hepatoblastoma and an increased incidence of mice with hepatocellular tumors in the treated mice. The rate of pulmonary metastases for hepatoblastoma was similar to that of pulmonary metastasis for hepatocellular carcinomas. Although a variety of chemicals caused an increased incidence of mice with hepatoblastoma, there was no apparent association between a specificchemical structure or a biological class of compounds and their capacity to induce hepatoblastomas. Hepatoblastomas frequently arose within hepatocellular carcinomas or adenoma s and were induced by the same compound s that induced hepatocellular neoplasms. Therefore, it seems reasonable to combine the incidence of mice with hepatoblastomas and the incidence of mice with hepatocellular carcinomas in hazard identification studies.
Key Words: Hepatocellular tumors adenoma rodent studies cancer B6C3F1 mice cancer rates bioassays 2-year studies embryonal tumors.
References
- Anna CH, Sills RC, Foley JF, Stockton PS, Ton T-V., Devereux TR (2000). β-Catenin mutations and protein accumulation in all hepatoblastoma s examined from mice treated with anthraquinone or oxazepam. Cancer Res 60: 2864—2868.[Abstract/Free Full Text]
- Beiler GS, Williams RL (1993). Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 49: 793— 801.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Boorman GA, Eustis SL (1986). The pathology working group as a means for assuring pathology quality in toxicological studies In: Managing Conduct and Data Quality of Toxicological Studies, Hoover BK, Baldwin JK, Uelner AF, Whitmire CE, Davies CL, Bristol DW (eds). Princeton Scientific Publishing Co, Princeton, New Jersey, pp 271—275.
- Bucher JR, Shackelford CC, Haseman JK, Johnson JD, Kurtz PJ, Persing RL (1994). Carcinogenicity studies of oxazepam in mice. Fundam Appl Toxicol 23: 280—297.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Buckley JD, Sather H., Riccione K., Rogers PC, Haas JE, Henderson BE, Hammond GD (1989). A case-control study of risk factors for hepatoblastoma. A report from the children's cancer study group. Cancer 64: 1169— 1176.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Carceller A., Blanchard H., Champangne J., St-Vil D., Bensoussan AL (2001). Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma. J Pediatr Surg 36: 755—759.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chhabra RS, Eustis SL, Haseman JK, Kurtz PJ, Carlton WW (1992). Comparative carcinogenicity of ethylene thiourea with or without perinatal exposure in rats and mice. Fundam Appl Toxicol 18: 405—417.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Diwan BA, Ward JW, Kurata Y., Rice JM ( 1994). Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbitol. Toxicol Pathol 22: 430— 439.[Abstract/Free Full Text]
- Diwan BA, Ward JW, Ramljak D., Anderson LM (1997). Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol Path 25: 597— 605.[Abstract/Free Full Text]
- Diwan BA, Ward JW, Rice JM ( 1989). Promotion of malignant `embryonal' liver tumors by phenobarbital: Increased incidence and shortened latency of hepatoblastomas in (DBS/2 x C57BL/6) F1 mice initiated by N-nitrosodiethylamine. Carcinogenesis 10: 1345—1348.[Abstract/Free Full Text]
- Feusner J., Buckley JD, Robison L., Ross JA, Van Tornout J. (1998). Pre-maturity and hepatoblastoma: More than just an association. J Pediatr 133: 585—586.[Web of Science][Medline]
[Order article via Infotrieve]
- Frith CH, Ward JW, Turusov VS (1994). Tumours of the liver. In Pathology of Tumours in Laboratory Animals. Volume 2—Tumours of the Mouse, Turusov VS, Mohr U (eds). IARC Scientific Publications, Lyon, pp 223—269.
- Gaylor DW, Kodell RL (2001). Dose-respons e trend tests for tumorigenesi s adjusted for differences in survival and body weight across doses. Toxicol Sci 59: 219—225.[Abstract/Free Full Text]
- Hailey JR, Haseman J., Bucher JR, Radovsky AE, Malarkey DE, Miller RT, Nyska A., Maronpot RR (1998). Impact of Helicobacter hepaticus in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol Pathol 26: 602—611.[Abstract/Free Full Text]
- Harada T., Enomoto A., Boorman GA, Maronpot RR (1999). Liver and gall-bladder. In Pathology of the Mouse, Maronpot RR, Boorman GA, Gaul BW (eds). Cache River Press, Vienna, Illinois, pp 119—184.
- Haseman JK, Hailey JR, Morris RW (1998). Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol Pathol 26: 428— 441.[Abstract/Free Full Text]
- Haseman JK, Huff JE, Rao GN, Arnold JE, Boorman GA, McConnell EE (1985). Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N x C3H/HeN) F1 (B6C3F1) mice. J Natl Cancer Inst 75: 975—984.[Web of Science][Medline]
[Order article via Infotrieve]
- Haseman JK, Young E., Eustis SL, Hailey JR (1997). Body weight-tumor correlations in long-term rodent carcinogenicity studies. Toxicol Pathol 25: 256—263.[Abstract/Free Full Text]
- Ishak KG, Glunz PR (1967). Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 20: 396—422.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Johnson JD, Ryan MJ, Tuft JD, Graves SW, Hejmancik MR, Cunningham ML, Herbert R., Abdo KM ( 2000). Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F12 mice. J Agric Food Chem 48: 3620—3632.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kharkovskaya NA, Svinolupova SI, Khrustalev SA, Engelhardt NV, Kondalenko VF, Poltoranina VS, Turusov VS (1990). Transplantable mouse hepatoblastoma: Histologic, ultrastructural and immunohistochemical study. Exp Pathol 40: 283—289.[Web of Science][Medline]
[Order article via Infotrieve]
- Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., Pietsch T. (1999). Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59: 269—273.[Abstract/Free Full Text]
- Lack EE, Neave C., Vawter GF (1982). Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 6: 693—705.[Web of Science][Medline]
[Order article via Infotrieve]
- Maronpot RR, Haseman JK, Boorman GA, Eustis SL, Rao GN, Huff JE (1987). Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. Arch Toxicol Suppl 10: 10—26.[Medline]
[Order article via Infotrieve]
- National Toxicology Program (NTP) (1992). Toxicology and carcinogenesi s studies of ethylene thiourea (CAS NO. 96-45-7) inF344/N rats and B6C3F1 mice (feed study) In: NTP Technical Report No. 388. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina.
- National Research Council (NRC) (1996). Guide for the Care and Use of Laboratory Animals, 7th ed, ILAR, Vol.1. National Academy Press, Washington, DC, p 125.
- National Toxicology Program (NTP) (1993). Toxicology and carcinogenesi s studies of o-nitroanisole (CAS NO. 91-23-6) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 416. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—473.
- National Toxicology Program (NTP) (1993). Toxicology and carcinogenesi s studies of oxazepam (CAS NO. 604-75-1) in Swiss-Webster B6C3F1 mice (feed studies). In: NTP Technical Report No. 443. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—316.
- National Toxicology Program (NTP) (1995). Toxicology and carcinogenesi s studies of methyphenidate hydrochloride (CAS NO. 298-59-9) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 439. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—294.
- National Toxicology Program (NTP) (1996). Toxicology and carcinogenesis studies of 1-amino-2,4-dibromoanthraquinon e (CAS NO. 81-49-2) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 383. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—370.
- National Toxicology Program (NTP) (1999). Toxicology and carcinogenesi s studies of anthraquinone (CAS NO. 86-65-1) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 494. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—325.
- National Toxicology Program (NTP) (1999). Toxicology and carcinogenesi s studies of diethanolamine (CAS NO. 111-42-2) in F344/N rats and B6C3F1 mice (dermal studies). In: NTP Technical Report No. 478. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—211.
- National Toxicology Program (NTP) (2000). Toxicology and carcinogenesis studies of methyleugenol (CAS NO. 93-15-2) in F344/N rats and B6C3F1 mice (gavage studies). In: NTP Technical Report No. 491. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—412.
- National Toxicology Program (NTP) (2000). Toxicology and carcinogenesi s studies of primidone (CAS NO. 125-33-7) in F344/N rats and B6C3F1 mice (feed studies). In: NTP Technical Report No. 476. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—290.
- National Toxicology Program (NTP) (2000). Toxicology and carcinogenesi s studies of pyridine (CAS NO. 110-86-1) in F344/N rats and B6C3F1 mice (drinking water studies). In: NTP Technical Report No. 470. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina, pp 1—327.
- National Toxicology Program (NTP) (2001). Toxicology and carcinogenesi s studies of coconut oil acid diethanolamine condensate (CAS NO. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies). In: NTP Technical Report No. 479. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Research TrianglePark, North Carolina, pp 1—226.
- Nonoyama T., Reznik G., Bucci TJ, Fullerton F. (1986). Hepatoblastoma with squamous differentiation in a B6C3F1 mouse. Vet Pathol 23: 619—622.[Web of Science][Medline]
[Order article via Infotrieve]
- Nyska A., Maronpot RR, Eldridge SR, Haseman JK, Hailey JR (1997). Alteration in cell kinetics in control B6C3F1 mice infected with Helicobacter hepaticus. Toxicol Path 25: 591—596.[Abstract/Free Full Text]
- Rao GN (1996). New diet (NTP 2000) for rats in the National Toxicology Program's toxicology and carcinogenesi s studies. Fundam Appl Toxicol 31: 102—108.
- Rao GN (1997). New nonpurifieddiet (NTP 2000) for rodents in the National Toxicology Program's toxicology and carcinogenesi s studies. J Nutr 127: 842S—846S.[Medline]
[Order article via Infotrieve]
- Rao GN (1999). Growth, body weight patterns, and life span of the B6C3F1 mouse. In: Pathology of the Mouse, Maronpot RR, Boorman GA, Gaul BW (eds). Cache River Press, Vienna, Illinois, pp 7—12.
- Reik W., Romer I., Barton SC, Surani MA, Howlett SK, Klose J. (1993). Adult phenotype in the mouse can be affected by epigenetic events in the early embryo. Development 119: 933—942.[Abstract/Free Full Text]
- Ross JA, Gurney JG (1998). Hepatoblastoma incidence in the United States from 1973 to 1992. Med Pediatr Oncol 30: 141—142.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sattler B., Gunawan B., Lorf T., Muller D., Ringe B., Fuzesi L. (2000). Undifferentiated small-cell hepatoblastoma. Pathologe 21: 456—459.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Snedecor GW, Cochran WG (1980). Statistical Methods, Vol. 1, 1980. Iowa State University Press, Ames, Iowa, pp 1—288.
- Tanimura M., Matsui I., Abe J., Ikeda H., Kobayashi N., Ohira M., Yokoyama M., Kaneko M. (1998). Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res 58: 3032—3035.[Abstract/Free Full Text]
- Turusov VS, Deringer MK, Dunn TB, Stewart HL (1973). Malignant liver tumor in mice resembling human hepatoblastoma. J Natl Cancer Inst 51: 1689—1695.[Web of Science][Medline]
[Order article via Infotrieve]
- Van Tornout J., Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA (1997). Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: A report from the Children's Cancer Group. J Clin Oncol 15: 1190—1197.[Abstract/Free Full Text]
- Warfel KA, Hull MT ( 1992). Hepatoblastomas—An ultrastructural and immunohistochemica l study. Ultrastr Path 16: 451—461.[CrossRef]
- Whitmore SP, Gilliam AF, Hendren RW, Lewis SE, Rao GN, Whisnant CC (1996). Genetic monitoring of inbred rodents from controlled production colonies through biochemical markers and skin grafting procedures. Lab An Sci 46: 585—588.
Toxicologic Pathology, Vol. 30, No. 5,
580-591 (2002)
DOI: 10.1080/01926230290105802

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Kim, R. C. Sills, and C. D. Houle
Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver
Toxicol Pathol,
January 1, 2005;
33(1):
175 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|